{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:36:21Z","timestamp":1789590981136,"version":"build-2803163510"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Hematology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1097\/01.moh.0000245693.39709.fa","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T15:03:54Z","timestamp":1161183834000},"page":"445-446","source":"Crossref","is-referenced-by-count":2,"title":["Variant Creutzfeldt\u2013Jacob disease \u2013 the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues"],"prefix":"10.1097","volume":"13","author":[{"given":"S Gerald","family":"Sandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Current Opinion in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00062752-200611000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:11:30Z","timestamp":1785939090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00062752-200611000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":0,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1097\/01.moh.0000245693.39709.fa","relation":{},"ISSN":["1065-6251"],"issn-type":[{"value":"1065-6251","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}